CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C03904 | BRD-K04745699 | BRD-K04745699 | -- | -- | -- | Details |
| C03905 | BRD-K04749191 | BRD-K04749191 | -- | -- | -- | Details |
| C03906 | BRD-K04750859 | BRD-K04750859 | -- | -- | -- | Details |
| C03907 | BRD-K04753511 | BRD-K04753511 | -- | -- | -- | Details |
| C03908 | BRD-K04757670 | BRD-K04757670 | -- | -- | -- | Details |
| C03909 | BRD-K04759195 | BRD-K04759195 | -- | -- | -- | Details |
| C03910 | BRD-K04762295 | BRD-K04762295 | -- | -- | -- | Details |
| C03911 | BRD-K04771555 | BRD-K04771555 | -- | -- | -- | Details |
| C03912 | BRD-K04772033 | BRD-K04772033 | -- | -- | -- | Details |
| C03913 | BRD-K04776289 | BRD-K04776289 | -- | -- | -- | Details |
| C03914 | BRD-K04779531 | BRD-K04779531 | -- | -- | -- | Details |
| C03915 | BRD-K04785821 | BRD-K04785821 | -- | -- | -- | Details |
| C03916 | BRD-K04786080 | BRD-K04786080 | -- | -- | -- | Details |
| C03917 | BRD-K04791118 | BRD-K04791118 | -- | -- | -- | Details |
| C03918 | BRD-K04798077 | BRD-K04798077 | -- | -- | -- | Details |
| C03919 | BRD-K04800985 | BRD-K04800985 | -- | -- | -- | Details |
| C03920 | BRD-K04801023 | SAR-245408 | -- | -- | -- | Details |
| C03921 | BRD-K04802065 | BRD-K04802065 | -- | -- | -- | Details |
| C03922 | BRD-K04803823 | BRD-K04803823 | -- | -- | -- | Details |
| C03923 | BRD-K04804440 | ciprofloxacin | -- | -- | -- | Details |
| C03924 | BRD-K04809113 | hydroxytyrosol | -- | -- | -- | Details |
| C03925 | BRD-K04810287 | BRD-K04810287 | -- | -- | -- | Details |
| C03926 | BRD-K04819729 | BRD-K04819729 | -- | -- | -- | Details |
| C03927 | BRD-K04831789 | BRD-K04831789 | -- | -- | -- | Details |
| C03928 | BRD-K04832618 | BRD-K04832618 | -- | -- | -- | Details |
| C03929 | BRD-K04833372 | GSK-1904529A | IGF1R; INSR | IGF-1 inhibitor; Insulin receptor ligand | -- | Details |
| C03930 | BRD-K04834648 | BRD-K04834648 | -- | -- | -- | Details |
| C03931 | BRD-K04847305 | BRD-K04847305 | -- | -- | -- | Details |
| C03932 | BRD-K04848570 | BRD-K04848570 | -- | -- | -- | Details |
| C03933 | BRD-K04853698 | LDN-193189 | BMPR1A; ACVR1 | Serine/threonine kinase inhibitor | -- | Details |
| C03934 | BRD-K04856990 | BRD-K04856990 | -- | -- | -- | Details |
| C03935 | BRD-K04873321 | BRD-K04873321 | -- | -- | -- | Details |
| C03936 | BRD-K04875192 | BRD-K04875192 | -- | -- | -- | Details |
| C03937 | BRD-K04877446 | BRD-K04877446 | -- | -- | -- | Details |
| C03938 | BRD-K04877770 | BRD-K04877770 | -- | -- | FTase-inhibitor-B581 | Details |
| C03939 | BRD-K04877855 | BRD-K04877855 | -- | -- | -- | Details |
| C03940 | BRD-K04882719 | BRD-K04882719 | -- | -- | -- | Details |
| C03941 | BRD-K04883440 | BRD-K04883440 | -- | -- | -- | Details |
| C03942 | BRD-K04883778 | BRD-K04883778 | -- | -- | -- | Details |
| C03943 | BRD-K04886976 | BRD-K04886976 | -- | -- | -- | Details |
| C03944 | BRD-K04887706 | BRD-K04887706 | -- | -- | AKT-inhibitor-1-2 | Details |
| C03945 | BRD-K04890734 | BRD-K04890734 | -- | -- | -- | Details |
| C03946 | BRD-K04905339 | SA-243929 | -- | -- | -- | Details |
| C03947 | BRD-K04905989 | BMS-270394 | -- | -- | -- | Details |
| C03948 | BRD-K04918285 | BRD-K04918285 | -- | -- | -- | Details |
| C03949 | BRD-K04919785 | BRD-K04919785 | -- | -- | -- | Details |
| C03950 | BRD-K04922291 | BRD-K04922291 | -- | -- | -- | Details |
| C03951 | BRD-K04923131 | BRD-K04923131 | -- | -- | GSK-3-inhibitor-IX | Details |
| C03952 | BRD-K04927711 | acea | -- | -- | -- | Details |
| C03953 | BRD-K04928505 | BRD-K04928505 | -- | -- | -- | Details |
| C03954 | BRD-K04930762 | BRD-K04930762 | -- | -- | -- | Details |
| C03955 | BRD-K04930806 | BRD-K04930806 | -- | -- | -- | Details |
| C03956 | BRD-K04937680 | BRD-K04937680 | -- | -- | -- | Details |
| C03957 | BRD-K04939366 | BRD-K04939366 | -- | -- | -- | Details |
| C03958 | BRD-K04949373 | parthenolide | -- | -- | -- | Details |
| C03959 | BRD-K04956647 | nebivolol | ADRB1 | Adrenergic receptor antagonist | -- | Details |
| C03960 | BRD-K04968881 | BRD-K04968881 | -- | -- | -- | Details |
| C03961 | BRD-K04969760 | BRD-K04969760 | -- | -- | -- | Details |
| C03962 | BRD-K04972057 | I-BRD9 | -- | -- | -- | Details |
| C03963 | BRD-K04976539 | aminogenistein | LCK | Src inhibitor | -- | Details |
| C03964 | BRD-K04980212 | BRD-K04980212 | -- | -- | -- | Details |
| C03965 | BRD-K04983929 | BRD-K04983929 | -- | -- | -- | Details |
| C03966 | BRD-K04985042 | BRD-K04985042 | -- | -- | -- | Details |
| C03967 | BRD-K04986062 | BRD-K04986062 | -- | -- | -- | Details |
| C03968 | BRD-K04992384 | BRD-K04992384 | -- | -- | -- | Details |
| C03969 | BRD-K04993501 | cefixime | -- | -- | -- | Details |
| C03970 | BRD-K04993719 | LY-2334737 | -- | -- | -- | Details |
| C03971 | BRD-K04993985 | BRD-K04993985 | -- | -- | -- | Details |
| C03972 | BRD-K05000526 | BRD-K05000526 | -- | -- | -- | Details |
| C03973 | BRD-K05001008 | BRD-K05001008 | -- | -- | -- | Details |
| C03974 | BRD-K05001416 | BRD-K05001416 | -- | -- | -- | Details |
| C03975 | BRD-K05002121 | BRD-K05002121 | -- | -- | -- | Details |
| C03976 | BRD-K05002317 | BRD-K05002317 | -- | -- | -- | Details |
| C03977 | BRD-K05004643 | BRD-K05004643 | -- | -- | -- | Details |
| C03978 | BRD-K05011302 | styrene | -- | -- | -- | Details |
| C03979 | BRD-K05015930 | BRD-K05015930 | -- | -- | -- | Details |
| C03980 | BRD-K05025838 | BRD-K05025838 | -- | -- | -- | Details |
| C03981 | BRD-K05032830 | BRD-K05032830 | -- | -- | -- | Details |
| C03982 | BRD-K05041276 | BRD-K05041276 | -- | -- | -- | Details |
| C03983 | BRD-K05041614 | BRD-K05041614 | -- | -- | -- | Details |
| C03984 | BRD-K05041765 | BRD-K05041765 | -- | -- | -- | Details |
| C03985 | BRD-K05050615 | BRD-K05050615 | -- | -- | -- | Details |
| C03986 | BRD-K05050883 | BRD-K05050883 | -- | -- | -- | Details |
| C03987 | BRD-K05051567 | BRD-K05051567 | -- | -- | -- | Details |
| C03988 | BRD-K05051664 | BRD-K05051664 | -- | -- | -- | Details |
| C03989 | BRD-K05057860 | BRD-K05057860 | -- | -- | -- | Details |
| C03990 | BRD-K05060234 | BRD-K05060234 | -- | -- | -- | Details |
| C03991 | BRD-K05068331 | BRD-K05068331 | -- | -- | -- | Details |
| C03992 | BRD-K05070188 | BRD-K05070188 | -- | -- | -- | Details |
| C03993 | BRD-K05071020 | BRD-K05071020 | -- | -- | -- | Details |
| C03994 | BRD-K05074020 | BRD-K05074020 | -- | -- | -- | Details |
| C03995 | BRD-K05076357 | BRD-K05076357 | -- | -- | -- | Details |
| C03996 | BRD-K05078233 | BRD-K05078233 | -- | -- | -- | Details |
| C03997 | BRD-K05086663 | BRD-K05086663 | -- | -- | -- | Details |
| C03998 | BRD-K05087650 | BRD-K05087650 | -- | -- | -- | Details |
| C03999 | BRD-K05090634 | BRD-K05090634 | -- | -- | -- | Details |
| C04000 | BRD-K05096562 | BRD-K05096562 | -- | -- | -- | Details |
| C04001 | BRD-K05098996 | BRD-K05098996 | -- | -- | -- | Details |
| C04002 | BRD-K05104363 | PD-184352 | MAP2K1 | MEK inhibitor | -- | Details |
| C04003 | BRD-K05111274 | BRD-K05111274 | -- | -- | -- | Details |